Is JNCE stock a buy?
What Is The Conclusion?
Right now our advanced algorithms say:
Do the analyst corps agree?
Interesting Questions and Easy Answers!
We cannot find any recorded dividends paid in our systems.
Sorry, we do not have any analyst data for this ticker
We cannot find data for Jounce Therapeutics Inc 10 years ago, but if you had invested on Friday 27th of January 2017 when the price was $17.25, you would have made a loss of $-15.37 per share or -89.10%
Yes, the average daily trading liquidity for Jounce Therapeutics Inc is $3.65 million. You should therefore be able to get in and out of your positions relatively fast.
Jounce Therapeutics Inc has no real debt, which is good in periods of high inflation. With a high cash flow to debt ratio of 2.76, the company's ability to pay off the debt is good. Jounce Therapeutics Inc has a very good net profit margin of 24.34% and should have very high tolerances against inflation.
We have calculated the inflation risk for Jounce Therapeutics Inc to be low [0 out of 1]